Literature DB >> 9878369

The X-ray structure of Escherichia coli enoyl reductase with bound NAD+ at 2.1 A resolution.

C Baldock1, J B Rafferty, A R Stuitje, A R Slabas, D W Rice.   

Abstract

Enoyl acyl carrier protein reductase catalyses the last reductive step of fatty acid biosynthesis, reducing an enoyl acyl carrier protein to an acyl-acyl carrier protein with NAD(P)H as the cofactor. The crystal structure of enoyl reductase (ENR) from Escherichia coli has been determined to 2.1 A resolution using a combination of molecular replacement and isomorphous replacement and refined using data from 10 A to 2.1 A to an R-factor of 0.16. The final model consists of the four subunits of the tetramer, wherein each subunit is composed of 247 of the expected 262 residues, and a NAD+ cofactor for each subunit of the tetramer contained in the asymmetric unit plus a total of 327 solvent molecules. There are ten disordered residues per subunit which form a loop near the nucleotide binding site which may become ordered upon substrate binding. Each monomer is composed of a seven-stranded parallel beta-sheet flanked on each side by three alpha-helices with a further helix lying at the C terminus of the beta-sheet. This fold is highly reminiscent of the Rossmann fold, found in many NAD(P)H-dependent enzymes. Analysis of the sequence and structure of ENR and comparisons with the family of short-chain alcohol dehydrogenases, identify a conserved tyrosine and lysine residue as important for catalytic activity. Modelling studies suggest that a region of the protein surface that contains a number of strongly conserved hydrophobic residues and lies adjacent to the nicotinamide ring, forms the binding site for the fatty acid substrate. Copyright 1998 Academic Press

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878369     DOI: 10.1006/jmbi.1998.2271

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Molecular basis for triclosan activity involves a flipping loop in the active site.

Authors:  X Qiu; C A Janson; R I Court; M G Smyth; D J Payne; S S Abdel-Meguid
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Crystallization and preliminary X-ray crystallographic analysis of enoyl-ACP reductase III (FabL) from Bacillus subtilis.

Authors:  Kook-Han Kim; Joon Kyu Park; Byung Hak Ha; Jin Ho Moon; Eunice EunKyeong Kim
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-02-28

3.  Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.

Authors:  Cheryl A Jordan; Braddock A Sandoval; Mkrtich V Serobyan; Damian H Gilling; Michael P Groziak; H Howard Xu; Jessica L Vey
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-11-27       Impact factor: 1.056

4.  In vitro reconstitution and steady-state analysis of the fatty acid synthase from Escherichia coli.

Authors:  Xingye Yu; Tiangang Liu; Fayin Zhu; Chaitan Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

5.  Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase.

Authors:  Suresh K Tipparaju; Stephen P Muench; Ernest J Mui; Sergey N Ruzheinikov; Jeffrey Z Lu; Samuel L Hutson; Michael J Kirisits; Sean T Prigge; Craig W Roberts; Fiona L Henriquez; Alan P Kozikowski; David W Rice; Rima L McLeod
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

6.  Characterization of protein-ligand binding interactions of enoyl-ACP reductase (FabI) by native MS reveals allosteric effects of coenzymes and the inhibitor triclosan.

Authors:  P Matthew Joyner; Denise P Tran; Muhammad A Zenaidee; Joseph A Loo
Journal:  Protein Sci       Date:  2021-12-15       Impact factor: 6.725

Review 7.  Bacterial Enoyl-Reductases: The Ever-Growing List of Fabs, Their Mechanisms and Inhibition.

Authors:  Fernanda S M Hopf; Candida D Roth; Eduardo V de Souza; Luiza Galina; Alexia M Czeczot; Pablo Machado; Luiz A Basso; Cristiano V Bizarro
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

8.  Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.

Authors:  Hao Lu; Peter J Tonge
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

9.  Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.

Authors:  Mili Kapoor; Jayashree Gopalakrishnapai; Namita Surolia; Avadhesha Surolia
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 10.  Fatty acid biosynthesis as a target for novel antibacterials.

Authors:  Richard J Heath; Charles O Rock
Journal:  Curr Opin Investig Drugs       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.